Additional Proxy Soliciting Materials (definitive) (defa14a)
April 25 2019 - 04:07PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C.
20549
SCHEDULE 14A
Proxy Statement Pursuant to
Section 14(a) of
the Securities Exchange Act of 1934
(Amendment No. )
|
Filed by the Registrant
x
|
|
|
|
Filed by a Party other than the
Registrant o
|
|
|
|
Check the
appropriate box:
|
|
o
|
Preliminary
Proxy Statement
|
|
o
|
Confidential, for Use of the
Commission Only (as permitted by Rule 14a-6(e)(2))
|
|
o
|
Definitive
Proxy Statement
|
|
x
|
Definitive
Additional Materials
|
|
o
|
Soliciting
Material under §240.14a-12
|
|
|
|
Albireo Pharma,
Inc.
|
|
(Name of Registrant as Specified In Its
Charter)
|
|
|
|
|
|
(Name of Person(s) Filing Proxy Statement, if
other than the Registrant)
|
|
|
|
Payment of
Filing Fee (Check the appropriate box):
|
|
x
|
No fee
required.
|
|
o
|
Fee computed
on table below per Exchange Act Rules 14a-6(i)(1) and
0-11.
|
|
|
(1)
|
Title of each
class of securities to which transaction applies:
|
|
|
|
|
|
|
(2)
|
Aggregate
number of securities to which transaction applies:
|
|
|
|
|
|
|
(3)
|
Per unit price
or other underlying value of transaction computed pursuant to
Exchange Act Rule 0-11 (set forth the amount on which the filing
fee is calculated and state how it was determined):
|
|
|
|
|
|
|
(4)
|
Proposed
maximum aggregate value of transaction:
|
|
|
|
|
|
|
(5)
|
Total fee
paid:
|
|
|
|
|
|
o
|
Fee paid
previously with preliminary materials.
|
|
o
|
Check box if
any part of the fee is offset as provided by Exchange Act Rule
0-11(a)(2) and identify the filing for which the offsetting fee was
paid previously. Identify the previous filing by registration
statement number, or the Form or Schedule and the date of its
filing.
|
|
|
(1)
|
Amount
Previously Paid:
|
|
|
|
|
|
|
(2)
|
Form, Schedule
or Registration Statement No.:
|
|
|
|
|
|
|
(3)
|
Filing
Party:
|
|
|
|
|
|
|
(4)
|
Date
Filed:
|
|
|
|
|
|
|
|
|
*** Exercise Your Right to Vote ***
Important Notice Regarding the Availability of Proxy Materials for
the Shareholder Meeting to Be Held on June 14, 2019 ALBIREO PHARMA
INC. Date: June 14, 2019 Time: 8:30 AM EDT You are receiving this
communication because you hold shares in the above named company.
This is not a ballot. You cannot use this notice to vote these
shares. This communication presents only an overview of the more
complete proxy materials that are available to you on the Internet.
You may view the proxy materials online at www.proxyvote.com or
easily request a paper copy (see reverse side). We encourage you to
access and review all of the important information contained in the
proxy materials before voting. Envelope # # of # Sequence # 1 OF 2
12 15 0000421644_1 R1.0.1.18 Broadridge Internal Use Only Job #
Sequence # See the reverse side of this notice to obtain proxy
materials and voting instructions. LOGO Return Address Line 1
Return Address Line 2 Return Address Line 3 51 MERCEDES WAY
EDGEWOOD NY 11717 Investor Address Line 1 Investor Address Line 2
Investor Address Line 3 Investor Address Line 4 Investor Address
Line 5 John Sample 1234 ANYWHERE STREET ANY CITY, ON A1A 1A1
1234567 1234567 1234567 1234567 1234567 1234567 BROKER HERE Meeting
Information Meeting Type: Annual Meeting For holders as of: April
17, 2019 Location: 10 Post Office Square Suite 502 South Boston, MA
02109 B A R C O D E
Before You Vote How to Access the
Proxy Materials Proxy Materials Available to VIEW or RECEIVE: Have
the information that is printed in the box marked by the arrow
(located on the by the arrow (located on the following page)
in the subject line. How To Vote Please Choose One of the Following
Voting Methods Only Vote By Mail: You can vote by mail by
requesting a paper copy of the materials, which will include a
voting instruction form. 0000421644_2 R1.0.1.18 Vote In Person: If
you choose to vote these shares in person at the meeting, you must
request a "legal proxy." To do so, please follow the instructions
at www.proxyvote.com or request a paper copy of the materials,
which will contain the appropriate instructions. Many shareholder
meetings have attendance requirements including, but not limited
to, the possession of an attendance ticket issued by the entity
holding the meeting. Please check the meeting materials for any
special requirements for meeting attendance. Vote By Internet: To
vote now by Internet, go to www.proxyvote.com. Have the information
that is printed in the box marked by the arrow available and follow
the instructions. Internal Use 1. Annual Report2. Notice &
Proxy Statement How to View Online: following page) and visit:
www.proxyvote.com. How to Request and Receive a PAPER or E-MAIL
Copy: If you want to receive a paper or e-mail copy of these
documents, you must request one. There is NO charge for requesting
a copy. Please choose one of the following methods to make your
request: 1) BY INTERNET:www.proxyvote.com 2) BY
TELEPHONE:1-800-579-1639 3) BY E-MAIL*:sendmaterial@proxyvote.com *
If requesting materials by e-mail, please send a blank e-mail with
the information that is printed in the box marked Requests,
instructions and other inquiries sent to this e-mail address will
NOT be forwarded to your investment advisor. Please make the
request as instructed above on or before June 02, 2019 to
facilitate timely delivery.
The Board of Directors recommends
that you vote FOR the following: 1. Election of Directors Nominees
01 David Chiswell, Ph.D. 02 Davey S. Scoon The Board of Directors
recommends you vote FOR the following proposal(s): 2. To approve
the amendment to the Albireo Pharma, Inc. 2018 Equity Incentive
Plan. 3. To ratify the appointment of Ernst & Young LLP as
Albireo's independent registered public accounting firm for the
fiscal year ending December 31, 2019. NOTE: Such other business as
may properly come before the meeting or any adjournment or
postponement thereof. xxxxxxxxxx Cusip Envelope # # of # Sequence #
0000421644_3 R1.0.1.18 Broadridge Internal Use Only xxxxxxxxxx Job
# Sequence # B A R C O D E 23456789012 2 2 2 2 12345678901
12345678901 12345678901 12345678901 12345678901 12345678901
12345678901 12345678901 12345678901 12345678901 Voting
items
Enve1lo2pe # # 0000421644_4
R1.0.1.18 Broadridge Internal Use Only THIS SPACE RESERVED FOR
SIGNATURES IF APPLICABLE P99999Jo-0b1#0 Sequ1e5nce # of #
S#eqOueFnce ## THIS SPACE RESERVED FOR LANGUAGE PERTAINING TO BANKS
AND BROKERS AS REQUIRED BY THE NEW YORK STOCK EXCHANGE Voting
Instructions Reserved for Broadridge Internal Control
Information
Albireo Pharma (NASDAQ:ALBO)
Historical Stock Chart
From Oct 2020 to Nov 2020
Albireo Pharma (NASDAQ:ALBO)
Historical Stock Chart
From Nov 2019 to Nov 2020
